{"name":"Mabion SA","slug":"mabion-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-31","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNNFdFVnROcnUwQWdHWVFCMWotRHR1bWxXUmdSWTBVWVZmdjBkdTlrUFRSUjhKTldpR3B1VkVEQ2dYaExfMkUtMWZyamRrYm5yR1A0NVBTVnJYeWcxWFZZZEw2YkVadmMyMXM3aFM2aERnenUyLVNSNGozcXJJSDRRYldUaHV2Vzg0MWxwekFxYTZ3bkNDRGFJ?oc=5","date":"2026-03-02","type":"pipeline","source":"Contract Pharma","summary":"The 2026 Biologics Wave: Which Innovations Will Break Through? - Contract Pharma","headline":"The 2026 Biologics Wave: Which Innovations Will Break Through?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTjctcnJZaU1fR0dLYlZselhtSC0yYmJhbFZBRklENzNIdzZPcU9INW5rRXBub2dVTGdrNkxEUTlWdVNYSnBtTTN1emlyUlZtc3hCT1c0WDRfdUVGT2U4NnZZUno1WGtTd01WR01ZS1d1Q3hoVUhiTGJwTTBEdmJ5aFJIUWlMd0E0VmlFRmxhLUY?oc=5","date":"2026-02-10","type":"pipeline","source":"PharmTech.com","summary":"Women in STEM: Unique Impacts in Rare Disease Development - PharmTech.com","headline":"Women in STEM: Unique Impacts in Rare Disease Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaTRzRzlTVlZ3bEc5RUhKZFhCY09aYVFXX2RQU2sxQkpsWmoydG5CeUNiZWVkSEppbnJTM0xfUWNVWWl4VHlPRUswVE9aRm0zcTFjZzc2cTVRd1YtOXJZczZ5LTZ2VnlIbFpVcDZGU3FZNE5OTmU5dkx1T2VDRUNTMWNiblRNcEszdlladHJhdEdOQkk0UUVTVmxKRU0?oc=5","date":"2025-06-30","type":"deal","source":"Contract Pharma","summary":"Mabion, NovalGen Partner to Bring NVG-222 to Market - Contract Pharma","headline":"Mabion, NovalGen Partner to Bring NVG-222 to Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNRGh5TUFTNnRLcmJfcVY1bFBSVGJXOXBGZmZYWk53aktaV1RDNUxLa0RVWXhYZnpCdkFIMjhpOGJidXBTRzgyS2RfbVNtd2pHc1JtZ2dFVEZfNHlRaUVGUkhETGxwWmZOa0Rxcmg2aS14TlpCSEw2cWJqbTRXYU5hM3Bwc1lnUEJUNHF3SUFja2R6UExVY3JEcGcyWWliS2kwZlVUbzZ6SEtsNmIwQTZyU2JjcG9nWUhCLTdjYmxhR3hMNjNDUnl2NmdYSjBQaTZDLVpWdk5ydE5hVG16UUozMWJpdnlESUVTVFZVTkx3RnRFWS1FaFFLeTkxUEtWdlhZalpzZ0lNa0NYajgxcmwzU001Z3g3d09mR0dSN1hBYnFQRndfVnNCX0RpRVlQVVc0RnRwSWJwYmdqZUU?oc=5","date":"2024-11-15","type":"earnings","source":"PR Newswire","summary":"Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics to drive revenue, Report with the AI impact on market trends - Technavio - PR Newswire","headline":"Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics to drive revenue, Report with","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}